13F-HR filed by Broadfin Capital, LLC
Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 39 holding rows worth $459,647,000.
- Accession
- 0001511901-19-000005
- Filer
- CIK 1511901
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 39 entries on the cover page, a total value of $459,647,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $459,647,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBroadfin Healthcare Master Fund Ltd 028-14254
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,559,299 | $38,234,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 7,258,135 | $37,452,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 488,265 | $31,654,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 676,879 | $29,641,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 1,053,314 | $21,161,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 200,000 | $20,600,000 | thousands by filing date | call |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 4,281,943 | $19,911,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 114,804 | $19,222,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 1,656,137 | $17,555,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 400,000 | $17,516,000 | thousands by filing date | call |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 316,619 | $16,654,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 344,762 | $16,473,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 1,561,617 | $15,882,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 657,998 | $12,232,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 2,765,070 | $10,618,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 500,000 | $10,045,000 | thousands by filing date | put |
| DEXCOM INC COM | 252131107 | Stock | 63,300 | $9,485,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 3,102,673 | $8,967,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 1,400,000 | $8,624,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 891,760 | $8,249,000 | thousands by filing date | |
| STRATA SKIN SCIENCES INC | 86272A206 | COMMON | 3,256,615 | $8,109,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 2,544,839 | $7,965,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 866,500 | $7,634,000 | thousands by filing date | |
| SOL GEL TECHNOLOGIES | M8694L103 | SHS | 730,100 | $6,649,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 312,898 | $6,364,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 639,756 | $5,982,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 1,744,147 | $5,738,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 66,600 | $5,658,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 291,000 | $5,642,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 258,150 | $4,876,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 595,900 | $4,219,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 126,400 | $3,769,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 123,785 | $3,439,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 150,000 | $3,014,000 | thousands by filing date | call |
| ADMA BIOLOGICS INC | 000899104 | COM | 747,500 | $2,893,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 441,088 | $2,735,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 74,786 | $2,270,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 100,000 | $1,859,000 | thousands by filing date | call |
| MATINAS BIOPHARMA HLDGS INC | 576810105 | COM | 766,708 | $657,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001511901-19-000005 | this filing | 2019-08-14 | acceptance time not in the bulk data set |